GUFIC BIOSCIENCES
|
GUFIC BIOSCIENCES Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | |
|---|---|---|---|
| Profit Before Tax | ₹87 Cr | ₹94 Cr | ₹116 Cr |
| Adjustment | ₹65 Cr | ₹44 Cr | ₹34 Cr |
| Changes In working Capital | ₹-95 Cr | ₹7.44 Cr | ₹-130 Cr |
| Cash Flow after changes in Working Capital | ₹57 Cr | ₹145 Cr | ₹20 Cr |
| Cash Flow from Operating Activities | ₹45 Cr | ₹123 Cr | ₹-7.46 Cr |
| Cash Flow from Investing Activities | ₹-31 Cr | ₹-71 Cr | ₹-102 Cr |
| Cash Flow from Financing Activities | ₹32 Cr | ₹-37 Cr | ₹82 Cr |
| Net Cash Inflow / Outflow | ₹46 Cr | ₹15 Cr | ₹-27 Cr |
| Opening Cash & Cash Equivalents | ₹16 Cr | ₹1.14 Cr | ₹29 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - |
| Closing Cash & Cash Equivalent | ₹62 Cr | ₹16 Cr | ₹1.14 Cr |
Compare Cashflow Statement of peers of GUFIC BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUFIC BIOSCIENCES | ₹4,192.0 Cr | -0.6% | 10.5% | 19.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹458,249.0 Cr | 1.8% | -1.6% | 16.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | -1.2% | 17.3% | 38.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,891.0 Cr | -2.3% | -2% | 33.6% | Stock Analytics | |
| CIPLA | ₹115,927.0 Cr | 0.2% | 1.7% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,702.0 Cr | 1.2% | 3.6% | -7% | Stock Analytics | |
GUFIC BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUFIC BIOSCIENCES | -0.6% |
10.5% |
19.3% |
| SENSEX | -0.5% |
1.3% |
-4% |
You may also like the below Video Courses